Phase 3 Refractory Chronic Cough Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Refractory Chronic CoughCough
Bellus Health Inc. - a GSK company975 enrolled242 locationsNCT05600777
Completed
Phase 3
Pregabalin and Speech Pathology Treatment for Chronic Cough
Idiopathic and Refractory Chronic Cough
John Hunter Hospital56 enrolled1 locationACTRN12611001186943